A growing Silicon Valley trend promoting continuous body monitoring through wearables and apps has physicians concerned. Companies like Apple, Oura, and Whoop market devices tracking heart rate variability, sleep stages, glucose levels, and more, promising optimized health through data.

Doctors argue this flood of information often lacks clinical context, leading to unnecessary anxiety, false positives, and overtreatment. Dr. Megan Ranney of Brown University warns that "more data doesn't equal better health" when patients misinterpret normal fluctuations as pathology.

Studies show 25% of wearable users report increased health anxiety. The FDA regulates few consumer devices as medical tools, leaving accuracy standards voluntary. Meanwhile, primary care visits surge with patients presenting app-generated alerts requiring clinical validation.

Experts suggest focusing on actionable metrics — blood pressure, activity levels — rather than chasing granular biomarkers. The trend reflects a cultural shift toward self-quantification, but medical consensus urges skepticism toward unvalidated health optimization promises.